| 1 |
34382383 |
10.3324/haematol.2020.263251 |
2022 |
Whole-genome profiling of primary cutaneous anaplastic large cell lymphoma. |
PRDM1 |
| 2 |
34844236 |
10.1159/000520070 |
2022 |
Dysregulated MDR1 by PRDM1/Blimp1 Is Involved in the Doxorubicin Resistance of Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma. |
PRDM1 |
| 3 |
34980830 |
10.1097/PAS.0000000000001859 |
2022 |
Clinicopathologic and Genetic Features of Primary T-cell Lymphomas of the Central Nervous System: An Analysis of 11 Cases Using Targeted Gene Sequencing. |
PRDM1 |
| 4 |
35429891 |
10.1016/j.prp.2022.153860 |
2022 |
The genetic deletion and protein expression of PRDM1 and its clinical implications in diffuse large B cell lymphoma: A retrospective cohort study in China. |
PRDM1 |
| 5 |
35444638 |
10.3389/fimmu.2022.871096 |
2022 |
Labial Gland Mesenchymal Stem Cell Derived Exosomes-Mediated miRNA-125b Attenuates Experimental Sjogren's Syndrome by Targeting PRDM1 and Suppressing Plasma Cells. |
PRDM1 |
| 6 |
35697790 |
10.1038/s41375-022-01623-z |
2022 |
Genomic profiling identifies distinct genetic subtypes in extra-nodal natural killer/T-cell lymphoma. |
PRDM1 |
| 7 |
35759728 |
10.1182/blood.2022015926 |
2022 |
Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphoma. |
PRDM1 |
| 8 |
35794478 |
10.1038/s41586-022-04906-8 |
2022 |
Super-enhancer hypermutation alters oncogene expression in B cell lymphoma. |
PRDM1 |
| 9 |
32273478 |
10.3324/haematol.2020.251579 |
2021 |
Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma. |
PRDM1 |
| 10 |
32732362 |
10.3324/haematol.2020.254276 |
2021 |
Genetic manipulation of primary human natural killer cells to investigate the functional and oncogenic roles of PRDM1. |
PRDM1 |
| 11 |
33199235 |
10.1016/j.intimp.2020.107137 |
2021 |
Agrimophol suppresses RANKL-mediated osteoclastogenesis through Blimp1-Bcl6 axis and prevents inflammatory bone loss in mice. |
PRDM1 |
| 12 |
33426772 |
10.1111/cas.14806 |
2021 |
Genetic profile of adult T-cell leukemia/lymphoma in Okinawa: Association with prognosis, ethnicity, and HTLV-1 strains. |
PRDM1 |
| 13 |
33569430 |
10.21037/atm-20-7574 |
2021 |
Molecular profiling of Chinese systemic anaplastic large cell lymphoma patients: novel evidence of genetic heterogeneity. |
PRDM1 |
| 14 |
33629212 |
10.1007/s12032-021-01470-5 |
2021 |
Identification BCL6 and miR-30 family associating with Ibrutinib resistance in activated B-cell-like diffuse large B-cell lymphoma. |
PRDM1 |
| 15 |
34236648 |
10.1007/978-1-0716-1669-7_20 |
2021 |
Generation and Surgical Analysis of Genetic Mouse Models to Study NF-κB-Driven Pathogenesis of Diffuse Large B Cell Lymphoma. |
PRDM1 |
| 16 |
34484219 |
10.3389/fimmu.2021.716240 |
2021 |
Coupled Antigen and BLIMP1 Asymmetric Division With a Large Segregation Between Daughter Cells Recapitulates the Temporal Transition From Memory B Cells to Plasma Cells and a DZ-to-LZ Ratio in the Germinal Center. |
PRDM1 |
| 17 |
35008340 |
10.3390/cancers14010176 |
2021 |
Recent Advances in the Genetic of MALT Lymphomas. |
PRDM1 |
| 18 |
31725418 |
10.1097/PAP.0000000000000253 |
2020 |
Lymphoid Neoplasms With Plasmablastic Differentiation: A Comprehensive Review and Diagnostic Approaches. |
PRDM1 |
| 19 |
31980558 |
10.1136/jclinpath-2019-206282 |
2020 |
Diagnostic value of bone marrow core biopsy patterns in lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia and description of its mutational profiles by targeted NGS. |
PRDM1 |
| 20 |
32012328 |
10.1002/hon.2718 |
2020 |
High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas. |
PRDM1 |
| 21 |
32127923 |
10.1177/1758835919900856 |
2020 |
Epigenetic aberrations in natural killer/T-cell lymphoma: diagnostic, prognostic and therapeutic implications. |
PRDM1 |
| 22 |
32533097 |
10.1038/s41388-020-1347-8 |
2020 |
The BLIMP1-EZH2 nexus in a non-Hodgkin lymphoma. |
PRDM1 |
| 23 |
32565964 |
10.3892/ol.2020.11552 |
2020 |
Comprehensive characterization of driver genes in diffuse large B cell lymphoma. |
PRDM1 |
| 24 |
32679859 |
10.3390/cancers12071912 |
2020 |
Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like Type. |
PRDM1 |
| 25 |
33017467 |
10.1182/bloodadvances.2020002049 |
2020 |
The synergistic proapoptotic effect of PARP-1 and HDAC inhibition in cutaneous T-cell lymphoma is mediated via Blimp-1. |
PRDM1 |
| 26 |
33252851 |
10.1002/ctm2.221 |
2020 |
Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma. |
PRDM1 |
| 27 |
33463110 |
10.18502/ijaai.v19i4.4118 |
2020 |
Increased Expression of B Lymphocyte Induced Maturation Protein 1 (BLIMP1) in Patients with Common Variable Immunodeficiency (CVID). |
PRDM1 |
| 28 |
33613551 |
10.3389/fimmu.2020.620716 |
2020 |
Multiscale Modeling of Germinal Center Recapitulates the Temporal Transition From Memory B Cells to Plasma Cells Differentiation as Regulated by Antigen Affinity-Based Tfh Cell Help. |
PRDM1 |
| 29 |
30348636 |
10.1158/1078-0432.CCR-18-1153 |
2019 |
Pan-HDAC Inhibitors Restore PRDM1 Response to IL21 in CREBBP-Mutated Follicular Lymphoma. |
PRDM1 |
| 30 |
30894186 |
10.1186/s12920-018-0437-8 |
2019 |
Analyzing the 3D chromatin organization coordinating with gene expression regulation in B-cell lymphoma. |
PRDM1 |
| 31 |
30935402 |
10.1186/s13045-019-0716-7 |
2019 |
Molecular pathogenic pathways in extranodal NK/T cell lymphoma. |
PRDM1 |
| 32 |
31002364 |
10.3892/or.2019.7112 |
2019 |
JAK3/STAT3 oncogenic pathway and PRDM1 expression stratify clinicopathologic features of extranodal NK/T‑cell lymphoma, nasal type. |
PRDM1 |
| 33 |
31024321 |
10.3389/fphar.2019.00367 |
2019 |
Inhibitory Effect of KP-A038 on Osteoclastogenesis and Inflammatory Bone Loss Is Associated With Downregulation of Blimp1. |
PRDM1 |
| 34 |
31378966 |
10.1002/ajh.25600 |
2019 |
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network. |
PRDM1 |
| 35 |
31607324 |
10.19746/j.cnki.issn.1009-2137.2019.05.042 |
2019 |
[Deubiquitinase MYSM1 Regulates Differentiation of Human B Cells to Plasma Cells]. |
PRDM1 |
| 36 |
31806993 |
10.2147/OTT.S227122 |
2019 |
Genomic Alterations In Primary Cardiac Diffuse Large B Cell Lymphoma: A Case Report And Literature Review. |
PRDM1 |
| 37 |
28573896 |
10.1080/10428194.2017.1330470 |
2018 |
Expression of a truncated B lymphocyte-induced maturation protein-1 isoform is associated with an incomplete plasmacytic differentiation program in chronic lymphocytic leukemia. |
PRDM1 |
| 38 |
29325247 |
10.3760/cma.j.issn.0529-5807.2018.01.006 |
2018 |
[Impact of PRDM1 gene inactivation on C-MYC regulation in diffuse large B-cell lymphoma]. |
PRDM1 |
| 39 |
29463002 |
10.3390/ijms19020601 |
2018 |
Inhibitory Effect of Purpurogallin on Osteoclast Differentiation in Vitro through the Downregulation of c-Fos and NFATc1. |
PRDM1 |
| 40 |
29781221 |
10.1002/art.40556 |
2018 |
Aberrant Expansion and Function of Follicular Helper T Cell Subsets in IgG4-Related Disease. |
PRDM1 |
| 41 |
29891112 |
10.1016/j.critrevonc.2018.05.010 |
2018 |
Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunities. |
PRDM1 |
| 42 |
29966370 |
10.3390/ijms19071931 |
2018 |
The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation. |
PRDM1 |
| 43 |
30274972 |
10.1158/2159-8290.CD-18-0657 |
2018 |
TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis. |
PRDM1 |
| 44 |
30612403 |
10.3760/cma.j.issn.0253-2727.2018.12.008 |
2018 |
[PRDM1 expression and its relationship with PI3K/AKT pathway activation in extranodal NK/T cell lymphoma-nasal type]. |
PRDM1 |
| 45 |
27568520 |
10.1038/leu.2016.243 |
2017 |
Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma. |
PRDM1 |
| 46 |
27687004 |
10.1038/modpathol.2016.162 |
2017 |
Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1. |
PRDM1 |
| 47 |
27704586 |
10.1002/hon.2362 |
2017 |
Hypermethylation of PRDM1/Blimp-1 promoter in extranodal NK/T-cell lymphoma, nasal type: an evidence of predominant role in its downregulation. |
PRDM1 |
| 48 |
27775850 |
10.1111/his.13106 |
2017 |
Clinicopathological characteristics and genomic profile of primary sinonasal tract diffuse large B cell lymphoma (DLBCL) reveals gain at 1q31 and RGS1 encoding protein; high RGS1 immunohistochemical expression associates with poor overall survival in DLBCL not otherwise specified (NOS). |
PRDM1 |
| 49 |
27924626 |
10.14670/HH-11-852 |
2017 |
Expression of the activation markers Blimp1, Foxp1 and pStat3 in extranodal diffuse large B-cell lymphomas. |
PRDM1 |
| 50 |
27941793 |
10.1038/nm.4252 |
2017 |
Fasting selectively blocks development of acute lymphoblastic leukemia via leptin-receptor upregulation. |
PRDM1 |
| 51 |
28378641 |
10.1177/1010428317695929 |
2017 |
Downregulation of PRDM1 promotes cellular invasion and lung cancer metastasis. |
PRDM1 |
| 52 |
28412245 |
10.1016/j.yexcr.2017.04.014 |
2017 |
CXCR5<sup>+</sup>CD8<sup>+</sup> T cells infiltrate the colorectal tumors and nearby lymph nodes, and are associated with enhanced IgG response in B cells. |
PRDM1 |
| 53 |
28468592 |
10.1177/1010428317701648 |
2017 |
Whole transcriptome analysis reveals dysregulated oncogenic lncRNAs in natural killer/T-cell lymphoma and establishes MIR155HG as a target of PRDM1. |
PRDM1 |
| 54 |
28474779 |
10.1002/ajh.24778 |
2017 |
A novel in vivo model for studying conditional dual loss of BLIMP-1 and p53 in B-cells, leading to tumor transformation. |
PRDM1 |
| 55 |
28479318 |
10.1016/j.jid.2017.04.010 |
2017 |
Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing. |
PRDM1 |
| 56 |
28494239 |
10.1016/j.chom.2017.04.005 |
2017 |
CRISPR/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors. |
PRDM1 |
| 57 |
28554762 |
10.1016/j.prp.2017.04.003 |
2017 |
Effect of plasma-activated medium on the decrease of tumorigenic population in lymphoma. |
PRDM1 |
| 58 |
28835384 |
10.1158/1535-7163.MCT-16-0840 |
2017 |
EZH2 Inhibition by Tazemetostat Results in Altered Dependency on B-cell Activation Signaling in DLBCL. |
PRDM1 |
| 59 |
28842558 |
10.1038/s41467-017-00476-w |
2017 |
HSP70-Hrd1 axis precludes the oncorepressor potential of N-terminal misfolded Blimp-1s in lymphoma cells. |
PRDM1 |
| 60 |
28858629 |
10.1016/j.molimm.2017.08.016 |
2017 |
Selective expression of the transcription elongation factor ELL3 in B cells prior to ELL2 drives proliferation and survival. |
PRDM1 |
| 61 |
29262531 |
10.18632/oncotarget.21986 |
2017 |
Mutational profile of primary breast diffuse large B-cell lymphoma. |
PRDM1 |
| 62 |
31966717 |
|
2017 |
PRDM1 expression levels in marginal zone lymphoma and lymphoplasmacytic lymphoma. |
PRDM1 |
| 63 |
26111727 |
10.1111/nan.12259 |
2016 |
Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas. |
PRDM1 |
| 64 |
26530011 |
10.1038/leu.2015.285 |
2016 |
EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis. |
PRDM1 |
| 65 |
26625717 |
10.1016/j.ejpb.2015.11.007 |
2016 |
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity. |
PRDM1 |
| 66 |
26727971 |
10.1002/pbc.25854 |
2016 |
Successful Treatment of Genetically Profiled Pediatric Extranodal NK/T-Cell Lymphoma Targeting Oncogenic STAT3 Mutation. |
PRDM1 |
| 67 |
27098601 |
10.1038/gene.2016.18 |
2016 |
Downregulation of ZBTB24 hampers the G0/1- to S-phase cell-cycle transition via upregulating the expression of IRF-4 in human B cells. |
PRDM1 |
| 68 |
27363279 |
|
2016 |
[Increased expressions of Blimp-1 and Bcl-6 in the deciduas of patients with unexplained recurrent spontaneous abortion]. |
PRDM1 |
| 69 |
27436361 |
10.1126/scisignal.aad8953 |
2016 |
ROCK2 signaling is required to induce a subset of T follicular helper cells through opposing effects on STATs in autoimmune settings. |
PRDM1 |
| 70 |
27539853 |
10.1074/jbc.M116.738617 |
2016 |
Kruppel-like Factor 6 Promotes Macrophage-mediated Inflammation by Suppressing B Cell Leukemia/Lymphoma 6 Expression. |
PRDM1 |
| 71 |
27764808 |
10.18632/oncotarget.12680 |
2016 |
The feedback loop of LITAF and BCL6 is involved in regulating apoptosis in B cell non-Hodgkin's-lymphoma. |
PRDM1 |
| 72 |
28056297 |
10.3760/cma.j.issn.0529-5807.2016.12.004 |
2016 |
[Potential mechanism and prognostic value of promoter methylation of PRDM1 gene in diffuse large B cell lymphoma]. |
PRDM1 |
| 73 |
25115512 |
10.3109/10428194.2014.953155 |
2015 |
PRDM1/BLIMP1: a tumor suppressor gene in B and T cell lymphomas. |
PRDM1 |
| 74 |
25487076 |
10.3109/10428194.2014.994181 |
2015 |
Methylation contributes to imbalance of PRDM1α/PRDM1bβ expression in diffuse large B-cell lymphoma. |
PRDM1 |
| 75 |
25533804 |
10.1038/leu.2014.347 |
2015 |
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation. |
PRDM1 |
| 76 |
25559471 |
10.1111/bjh.13265 |
2015 |
Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas. |
PRDM1 |
| 77 |
25991819 |
10.1158/1078-0432.CCR-14-2116 |
2015 |
Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas. |
PRDM1 |
| 78 |
26054109 |
|
2015 |
Decreased Bcl-6 and increased Blimp-1 in the peritoneal cavity of patients with endometriosis. |
PRDM1 |
| 79 |
26206802 |
10.3324/haematol.2015.126854 |
2015 |
Antineoplastic effects of liposomal short interfering RNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma. |
PRDM1 |
| 80 |
26221594 |
10.1155/2015/435423 |
2015 |
The Genetic Deletion of 6q21 and PRDM1 and Clinical Implications in Extranodal NK/T Cell Lymphoma, Nasal Type. |
PRDM1 |
| 81 |
26289642 |
10.1182/blood-2015-02-626176 |
2015 |
The forkhead transcription factor FOXP1 represses human plasma cell differentiation. |
PRDM1 |
| 82 |
26431332 |
10.1371/journal.ppat.1005195 |
2015 |
Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells. |
PRDM1 |
| 83 |
26460037 |
10.1073/pnas.1507312112 |
2015 |
Bcl6 middle domain repressor function is required for T follicular helper cell differentiation and utilizes the corepressor MTA3. |
PRDM1 |
| 84 |
24030746 |
10.1038/modpathol.2013.156 |
2014 |
Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma. |
PRDM1 |
| 85 |
24240734 |
10.1007/s00401-013-1202-x |
2014 |
Systems biology of primary CNS lymphoma: from genetic aberrations to modeling in mice. |
PRDM1 |
| 86 |
24306881 |
10.1007/s12253-013-9724-z |
2014 |
Hodgkin disease therapy induced second malignancy susceptibility 6q21 functional variants in roma and hungarian population samples. |
PRDM1 |
| 87 |
24376268 |
10.4049/jimmunol.1300420 |
2014 |
Premature terminal differentiation protects from deregulated lymphocyte activation by ITK-Syk. |
PRDM1 |
| 88 |
24438193 |
10.1186/1756-9966-33-7 |
2014 |
The downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type. |
PRDM1 |
| 89 |
24487434 |
10.1038/nm.3442 |
2014 |
Fas ligand-mediated immune surveillance by T cells is essential for the control of spontaneous B cell lymphomas. |
PRDM1 |
| 90 |
24821775 |
10.1073/pnas.1400958111 |
2014 |
Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia. |
PRDM1 |
| 91 |
25203537 |
10.1016/j.ajpath.2014.07.011 |
2014 |
HACE1, a potential tumor suppressor gene on 6q21, is not involved in extranodal natural killer/T-cell lymphoma pathophysiology. |
PRDM1 |
| 92 |
25205514 |
10.1158/1055-9965.EPI-14-0683 |
2014 |
Genetic associations in classical hodgkin lymphoma: a systematic review and insights into susceptibility mechanisms. |
PRDM1 |
| 93 |
25232062 |
10.1182/blood-2014-07-590570 |
2014 |
FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma. |
PRDM1 |
| 94 |
25382611 |
10.1038/bcj.2014.75 |
2014 |
Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma. |
PRDM1 |
| 95 |
23269792 |
10.1128/JVI.03003-12 |
2013 |
Different patterns of Epstein-Barr virus latency in endemic Burkitt lymphoma (BL) lead to distinct variants within the BL-associated gene expression signature. |
PRDM1 |
| 96 |
23355206 |
10.1309/AJCP0YGM8BLFYHJY |
2013 |
Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia. |
PRDM1 |
| 97 |
23599149 |
10.1038/modpathol.2013.73 |
2013 |
ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements. |
PRDM1 |
| 98 |
23768641 |
10.1016/j.beha.2013.04.006 |
2013 |
Molecular underpinning of extranodal NK/T-cell lymphoma. |
PRDM1 |
| 99 |
23980171 |
10.1073/pnas.1309378110 |
2013 |
The transcription factor Interferon Regulatory Factor 4 is required for the generation of protective effector CD8+ T cells. |
PRDM1 |
| 100 |
24004669 |
10.1182/blood-2013-04-497933 |
2013 |
PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma. |
PRDM1 |
Datasets
Models
